Ki-67 expression increased gradually from grades I to IV and was significantly higher in HGG patients than in LGG patients (P <0.05), regardless of glioma type, IDH1 mutation, or wild type (Figures 2A–D). This evidence concerns the gene MKI67 and central nervous system cancer.